The Discounted Cash Flow (DCF) valuation of Basilea Pharmaceutica AG (BSLN.SW) is 39.46 CHF. With the latest stock price at 40.30 CHF, the upside of Basilea Pharmaceutica AG based on DCF is -2.1%.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 7.9% | 6.6% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 22.28 - 162.62 | 39.46 |
| Upside | -44.7% - 303.5% | -2.1% |